CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
CURATIVE focuses on developing a chitosan-based nanoparticle to deliver a combination of drugs targeting cancer stem cells in neuroblastoma, a severe childhood cancer. This innovative approach aims to improve treatment efficacy, reduce side effects, and enhance the quality of life for young patients.
Neuroblastoma (NB) is a highly aggressive paediatric cancer, accounting for 15% of childhood cancer deaths.
The 5-year survival rate for high-risk NB patients is less than 50%.
Despite the significant advances in treatment options, the high tumour heterogeneity, drug resistance, and severe toxicities associated with conventional therapies continue to result in poor outcomes for high-risk NB patients.
Recent studies showed that these challenges, along with frequent relapses, may be linked to the…
UNIVERSIDAD DE NAVARRA
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
